TransMedics Group, Inc.
NasdaqGM-TMDX
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
Dec '24
LTM
Dec '25 (E)
Dec '26 (E)
Dec '27 (E)
| Assets | LTM | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 |
|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | 466.2 | 336.7 | 394.8 | 201.2 | 25.6 | 24.6 | 20.1 | 20.2 |
Short-Term Investments | — | — | — | — | 66.9 | 101.1 | 60.6 | — |
Total Cash and Cash Equivalents | 466.2 | 336.7 | 394.8 | 201.2 | 92.5 | 125.6 | 80.7 | 20.2 |
Accounts Receivable | 80.7 | 97.7 | 63.6 | 27.6 | 5.9 | 6.9 | 6.6 | 3.4 |
Total Trade Receivables | 80.7 | 97.7 | 63.6 | 27.6 | 5.9 | 6.9 | 6.6 | 3.4 |
Inventories | 44.5 | 46.6 | 44.2 | 20.6 | 14.9 | 11.9 | 11.2 | 9.3 |
Other Current Assets | 22.1 | 16.8 | 8.5 | 3.4 | 6 | 2.8 | 2 | 2.3 |
Total Current Assets | 613 | 497.2 | 510.7 | 252.3 | 118.7 | 146.8 | 100 | 34.8 |
Net Property, Plant & Equipment | 318.8 | 292.5 | 180.5 | 24.4 | 15.7 | 4.8 | 4.8 | 3.5 |
Net Intangible Assets | 2 | 2.2 | 2.4 | — | — | — | — | — |
Goodwill | 11.5 | 11.5 | 12 | — | — | — | — | — |
Other Long-Term Assets | 0.2 | 0.2 | 0.1 | — | — | 0 | 0 | 3.4 |
Total Assets | 946 | 804.1 | 706 | 277.1 | 134.9 | 152 | 105.3 | 42.2 |
| Liabilities | LTM | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 |
|---|---|---|---|---|---|---|---|---|
Accounts Payable | 12.2 | 10.3 | 12.7 | 3.3 | 6.7 | 1.2 | 7.2 | 4.7 |
Accrued Expenses | 56 | 45.2 | 38.2 | 18.6 | 16.3 | 10.4 | 8.3 | 7.2 |
Current Portion of Long-Term Debt | 5 | — | — | — | — | — | — | — |
Current Portion of Leases | 3.2 | 2.7 | 2 | 1.4 | — | — | 0.4 | 0.3 |
Unearned Revenue | 3.3 | 1.7 | 2 | 0.2 | 0.3 | 0.3 | 0.2 | 0.3 |
Other Current Liabilities | 56 | 45.2 | 38.2 | 18.6 | 16.3 | 10.4 | 8.3 | 7.2 |
Total Current Liabilities | 79.7 | 59.9 | 54.9 | 23.7 | 23.2 | 11.9 | 16.1 | 12.6 |
Long-Term Debt | 506.7 | 509.3 | 506.2 | 58.7 | 35.2 | 34.7 | 34.1 | 33.7 |
Leases | 4.4 | 6.2 | 7.7 | 7.4 | 8.6 | — | — | — |
Other Long-Term Liabilities | — | — | — | — | — | 1.6 | 0.4 | 1.7 |
Total Long-Term Liabilities | 511.1 | 515.6 | 513.9 | 66.1 | 43.8 | 36.3 | 34.5 | 35.3 |
Total Liabilities | 590.8 | 575.5 | 568.8 | 89.8 | 67 | 48.1 | 50.7 | 47.9 |
| Equity | LTM | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 |
|---|---|---|---|---|---|---|---|---|
Preferred Stock | — | — | — | — | — | — | — | 186.5 |
Common Stock | 738.4 | 697.2 | 641.1 | 666.3 | 510.5 | 502.2 | 424.1 | 0 |
Additional Paid-in Capital | — | — | — | — | — | — | — | 143.8 |
Accumulated Other Comprehensive Income | 0.1 | -0.4 | -0.2 | -0.2 | -0.2 | -0.1 | -0 | -0.1 |
Retained Earnings | -383.3 | -468.2 | -503.7 | -478.7 | -442.4 | -398.2 | -369.5 | -335.9 |
Total Common Shareholders' Equity | 355.2 | 228.6 | 137.2 | 187.4 | 67.9 | 103.9 | 54.6 | -192.2 |
Total Shareholders' Equity | 355.2 | 228.6 | 137.2 | 187.4 | 67.9 | 103.9 | 54.6 | -192.2 |
Total Liabilities and Shareholders' Equity | 946 | 804.1 | 706 | 277.1 | 134.9 | 152 | 105.3 | 42.2 |